Literature DB >> 11536155

Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus.

T Ostler1, T Hussell, C D Surh, P Openshaw, S Ehl.   

Abstract

In mice acutely infected with respiratory syncytial virus (RSV), more than 20% of pulmonary CD8(+) T cells, but only 2-3% of CD8(+) T cells in the draining lymph node secreted interferon-gamma in response to a single peptide. Surprisingly, the percentage of virus-specific T cells in the lung remained at these high levels long after the acute infection. Pulmonary memory T cells were further studied in a sensitive adoptive transfer system, which allows visualizing polyclonal CD4(+) and CD8(+) virus-specific memory T cell responses. Fifty days after infection, persisting RSV-specific pulmonary T cells remained CD69(hi) CD62L(lo), but had returned to a resting memory state according to functional criteria. In the absence of neutralizing antibodies reinfection first induced cell division among virus-specific memory T cells 3 days after infection predominantly in the local lymph node. However, divided cells then rapidly accumulated in the lung without significantly increasing in the lymph node. These results suggest rapid export of reactivated cells from the lymph node to the target organ. Thus, although memory T cells can be maintained in the infected organ after a localized virus infection, amplification of a recall response appears to be most effective in organized lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536155     DOI: 10.1002/1521-4141(200109)31:9<2574::aid-immu2574>3.0.co;2-v

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  T cell memory in the lung airways.

Authors:  David L Woodland; Iain Scott
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract.

Authors:  Peter M Gray; Subhashini Arimilli; Ellen M Palmer; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 4.  Aging and CD8+ T cell immunity to respiratory virus infections.

Authors:  Kenneth H Ely; Alan D Roberts; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  Exp Gerontol       Date:  2007-01-02       Impact factor: 4.032

5.  Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia.

Authors:  Hye Mee Joo; Yuxia He; Mark Y Sangster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

6.  Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection.

Authors:  Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

Review 7.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

Review 8.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

9.  Role of T cells in virus control and disease after infection with pneumonia virus of mice.

Authors:  Stefanie Frey; Christine D Krempl; Annette Schmitt-Gräff; Stephan Ehl
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen.

Authors:  Shiki Takamura; Alan D Roberts; Dawn M Jelley-Gibbs; Susan T Wittmer; Jacob E Kohlmeier; David L Woodland
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.